Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 7:30 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 313–336 of 360 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Pharmacist intervention Clear all

Conditions: Drug Toxicity
Interventions: HIE-Enhanced Medication Reconciliation, Optimal Medication Reconciliation without HIE; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years and older
Enrollment: 402 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Diabetes, Diabetes Type 2
Interventions: MTM, CHW; Behavioral
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 18 Years to 90 Years
Enrollment: 376 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Depressive Symptoms, Metabolic Syndrome X, Overweight, Obesity, Hypertension, Hyperglycemia, Dyslipidemias
Interventions: Generations older adult membership program, BRIGHTEN Heart Virtual Team intervention; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 60 Years to 110 Years
Enrollment: 250 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2014
U.S. locations: 2
States / cities: Chicago, Illinois

Conditions: COVID-19
Interventions: Standard implementation webinar and online training, Virtual facilitation; Behavioral
Lead sponsor: University of North Carolina, Chapel Hill; Other
Eligibility: 18 Years and older
Enrollment: 16 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Polypharmacy, Deprescribing, Adverse Drug Reaction
Interventions: Deprescribing Intervention, Usual Care; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 65 Years and older
Enrollment: 419 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2022
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Opioid Use Disorder, Opioid Misuse, Chronic Pain
Interventions: TCM, TCM plus COPES; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years and older
Enrollment: 259 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2027
U.S. locations: 3
States / cities: Little Rock, Arkansas • Aurora, Colorado • West Haven, Connecticut

Conditions: Chronic Kidney Disease stage3, Chronic Kidney Disease stage4, Chronic Kidney Disease Stage 5, Patient Engagement
Interventions: CKD "What You Need To Know" Workbook System, CKD Action Plan, CKD Web-based Resource List, Food Label reading exercise; Other
Lead sponsor: University of Arkansas; Other
Eligibility: 18 Years to 105 Years
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Little Rock, Arkansas

Conditions: Aging, Emergencies
Interventions: PA4LE Program; Behavioral
Lead sponsor: University of Arizona; Other
Eligibility: 55 Years and older
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Tucson, Arizona

Conditions: Hypertension
Interventions: Pharmacists Only (Control Group), Combined Intervention (Pharmacists + CHW Interventions); Other
Lead sponsor: Texas Southern University; Other
Eligibility: 55 Years and older
Enrollment: 480 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Torsades de Pointe Caused by Drug (Disorder), Torsades de Pointes, Qt Interval, Variation in
Interventions: Pharmacist Intervention; Other
Lead sponsor: Northeast Iowa Medical Education Foundation; Other
Eligibility: 18 Years and older
Enrollment: 54 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 1
States / cities: Waterloo, Iowa

Conditions: Diabetes Mellitus, Type 2
Interventions: Pharmacist review of therapy; Other
Lead sponsor: Rutgers, The State University of New Jersey; Other
Eligibility: 18 Years to 75 Years
Enrollment: 239 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2019
U.S. locations: 1
States / cities: Trenton, New Jersey

Conditions: Opioid Misuse
Interventions: Text Message, Standard of Care; Other
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 479 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Winston-Salem, North Carolina

Conditions: Pain Measurement
Interventions: Qualitative Interview; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 27 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Patient Admission, Patient Discharge
Interventions: Combined Social Worker and Pharmacist Program, No Intervention: Usual Care; Behavioral
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Acute Coronary Syndrome, Heart Failure
Interventions: Pharmacist Intervention for Low-Literacy in Cardiovascular Disease; Behavioral
Lead sponsor: Vanderbilt University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 862 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2012
U.S. locations: 2
States / cities: Boston, Massachusetts • Nashville, Tennessee

Conditions: Chronic Disease
Interventions: Transitions of care; Behavioral
Lead sponsor: Auburn University; Other
Eligibility: 18 Years and older
Enrollment: 88 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Auburn, Alabama

Conditions: Laceration of Skin, Anxiety, Discharge Time
Interventions: Intranasal Midazolam, Intranasal Dexmedetomidine, Intranasal Ketamine; Drug
Lead sponsor: University of Oklahoma; Other
Eligibility: 1 Year to 5 Years
Enrollment: 90 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 1
States / cities: Oklahoma City, Oklahoma

Conditions: Polypharmacy
Interventions: Pharmacogenomic test; Diagnostic Test
Lead sponsor: Kaiser Permanente; Other
Eligibility: 18 Years to 79 Years
Enrollment: 600 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2027
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Smoking Cessation, Smoking Cessation Counseling Ability and Practice, Smoking Cessation Counselling, Lung Cancer Screening
Interventions: CONNECT Intervention for multilingual populations, Saliva Sample, Interview; Behavioral · Other
Lead sponsor: University of California, San Francisco; Other
Eligibility: 50 Years to 80 Years
Enrollment: 439 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Tobacco Use Cessation
Interventions: QuitAid, SmokefreeTXT, Nicotine Replacement Therapy Patch, Nicotine lozenge; Behavioral · Drug
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Frailty
Interventions: Intervention; Behavioral
Lead sponsor: Northwestern University; Other
Eligibility: 65 Years and older
Enrollment: 822 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Beta Lactam Allergy in Patients With a Hematologic Malignancy
Interventions: Semi-structured interview, Survey, Ethnographic observation; Behavioral
Lead sponsor: Abramson Cancer Center at Penn Medicine; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2029
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Cancer
Interventions: Pharmacist-led deprescribing, Patient education; Other
Lead sponsor: University of Rochester; Other
Eligibility: 65 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Hypertension, Cognitive Decline
Interventions: Virtual Collaborative Care Clinic; Other
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 33 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Kansas City, Kansas

Search by objective public record fields.

Regional Data Exchange to Improve Medication Safety

Enhancing Diabetes Management Approaches for Patients With Uncontrolled Diabetes

Reducing Disparities in Late Life Depression and Metabolic Syndrome

COVID-19 Vaccine Hesitancy Counseling Intervention for Pharmacists

Reducing Costs by Deprescribing Medications

Pain Care at Home to Amplify Function (Pain CHAMP)

A Pragmatic Approach to CKD Patient Education

Preventing Avoidable Admissions Among Assisted Living Elders

The "Check, Monitor, Control Hypertension" Study is a 24-month Randomized Trial in Houston Targeting African Americans Aged 55+. It Combines Pharmacist Counseling and CHW Support to Improve Blood Pressure Control in Hypertension Management.

Pharmacist Use of ECG to Inform Drug Therapy Decisions for Patients Receiving QT Prolonging Medications

Effect of Pharmacists Treating Diabetes in a FQHC

Text Intervention to Facilitate Secure Storage and Disposal of Prescription Opioids

COA-APTIC Clinician Concept Elicitation Study

Combined Social Worker and Pharmacist Transitional Care Program

Pharmacist Intervention to Decrease Medication Errors in Heart Disease Patients (The PILL-CVD Study)

A Pharmacist-led Transitions of Care Program

IN Midazolam vs IN Dexmedetomidine vs IN Ketamine During Minimal Procedures in Pediatric ED

Effectiveness of PGx Testing

Evaluating the Impact of CONNECT in a Multilingual Population

Feasibility of Delivering VergeRx at FQHCs

A Randomized Controlled Trial of Geriatric Emergency Department Innovations

Allergy Delabeling in Antibiotic Stewardship - Evaluations

Decreasing Polypharmacy in Older Adults With Curable Cancers Trial

Remote Monitoring and Virtual Collaborative Care For Hypertension Control To Prevent Cognitive Decline